LABSCO will continue to operate under the LABSCO name and serve 8,000 customers currently served by the company.

The LABSCO leadership team will be strengthened by adding two healthcare distribution industry veterans Steve Nielsen and Dan Eckert.
Activus Healthcare Solutions founder and former CEO and General Medical CEO Steve Nielsen will become Chairman and CEO while former president and CEO of PolyRemedy Dan Eckert will become president and COO of LABSCO.

The founder of LABSCO, Charlie Davis, will remain on the LABSCO Board and will continue to work with the management team during the ownership transition.

Frazier Healthcare provides growth equity and venture capital to high growth and emerging healthcare service, biopharma and medical device companies.